SCHEMBL3576853

SCHEMBL3576853

[c]1sccc1-c1ccsc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 8/20 0.43
CYP2B6 P20813 3/20 0.43
CYP2E1 P05181 2/20 0.43
KCNH2 Q12809 1/20 0.36
TDO2 P48775 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
PRMT6 Q96LA8 1/20 0.33
IKBKB O14920 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
CYP17A1 P05093 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM1 P11229 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL276590 0.74
SCHEMBL3459789 0.71 CYP2A6 (0.41) CYP2A6CYP2B6CYP2E1KCNH2TDO2
SCHEMBL4591164 0.70 CYP1A2 (0.39) CYP2A6TDO2IKBKBALDH1A1MAPT
SCHEMBL7615765 0.67 CYP2A6 (0.41) CYP2A6CYP2B6CYP2E1KCNH2CYP3A4
SCHEMBL1439053 0.67 CYP2A6 (0.52) CYP2A6CYP2B6CYP2E1KCNH2TDO2
SCHEMBL17350220 0.65 CYP2A6 (0.40) CYP2A6CYP2B6CYP2E1KCNH2TDO2
SCHEMBL8096259 0.65 CYP2A6 (0.40) CYP2A6CYP2B6CYP2E1KCNH2TDO2
SCHEMBL6653596 0.64 CYP2A6 (0.43) CYP2A6CYP2B6CYP2E1KCNH2TDO2
SCHEMBL7865465 0.63 TAAR1 (0.41) CYP3A4ALDH1A1MAPTCYP17A1CYP11B1
SCHEMBL2315785 0.63 CYP2A6 (0.47) CYP2A6CYP2B6CYP2E1KCNH2TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0641208-B1 4-AZASTEROID 5-ALPHA-REDUCTASE INHIBITORS MERCK & CO INC (US) 2000-08-02 EP claimed
EP-0641208-A4 4-AZASTEROID 5-ALPHA-REDUCTASE INHIBITORS. MERCK & CO INC (US) 1995-08-30 EP claimed
EP-0641208-A1 4-AZASTEROID 5-ALPHA-REDUCTASE INHIBITORS MERCK & CO. INC. (US) 1995-03-08 EP claimed
WO-1993023048-A1 4-AZASTEROID 5-ALPHA-REDUCTASE INHIBITORS MERCK & CO., INC. (US) 1993-11-25 WO claimed
EP-0100527-B1 4H-1,4-BENZOTHIAZINES FOR USE AS MEDICAMENTS BAYER AG (DE) 1987-01-07 EP claimed
CN-104395289-B Amide compound and Pesticidal purposes thereof SUMITOMO CHEMICAL CO.,LTD. (JP) 2016-05-11 CN disclosed
WO-2012122171-A1 HERBICIDAL BIS-NITROGEN-CONTAINING OXO HETEROCYCLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-09-13 WO disclosed
US-7652060-B2 Neurotrophic N-glyoxyl-prolyl ester compounds e.g. 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; non-immunosuppressive; side effect reduction; neurodegenerative diseases Glia Med, Inc (US) 2010-01-26 US disclosed
EP-1636217-B1 2-IMIDAZO-BENZOTHIAZOLES AS ADENOSINE RECEPTOR LIGANDS HOFFMANN LA ROCHE (CH) 2008-09-03 EP disclosed
US-20080076817-A1 Small Molecule Rotamase Enzyme Inhibitors HAMILTON GREGORY S 2008-03-27 US disclosed
CN-100372844-C 2-imidazo-benzothiazoles as adenosine receptor ligands HOFFMANN LA ROCHE (CH) 2008-03-05 CN disclosed
CN-1780831-A 2-Imidazole-Benzothiazoles as Adenosine Receptor Ligands HOFFMANN LA ROCHE (CH) 2006-05-31 CN disclosed
US-4980367-A CONTROLLING PLANT DISEASES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-12-25 US disclosed
EP-0390850-A4 ANTIFUNGAL CARBINOLS 1990-12-05 EP disclosed
US-4965280-A PLANT GROWTH REGULATORS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-10-23 US disclosed
US-4965281-A CONTROLLING PLANT AND MAMMAL FUNGAL INFECTIONS E. I. DU PONT DE NEMOURS AND CMOPANY (US) 1990-10-23 US disclosed
EP-0390850-A1 ANTIFUNGAL CARBINOLS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1990-10-10 EP disclosed
US-4952232-A Antifungal carbinols E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-08-28 US disclosed
WO-1989005581-A1 ANTIFUNGAL CARBINOLS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1989-06-29 WO disclosed
US-4099001-A [[[Imidazolidinyl amino]carbonyl]amino]acetyl cephalosporin derivatives E. R. SQUIBB & SONS, INC. (US) 1978-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076817-A1 Small Molecule Rotamase Enzyme Inhibitors FKBP8, FKBP1A, FKBP2 CYP2A6 2628/4885CYP2B6 3249/4885CYP2E1 3974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.